Teva Publishes 2021 ESG Progress Report, Showcasing Further Integration of ESG Into Business, Robust Targets and Strengthened ESG Governance Structure
Zacks: Brokerages Expect Teva Pharmaceutical Industries Limited (NYSE:TEVA) to Announce $0.55 EPS - Defense World
Teva Pharmaceutical (TEVA)
Teva Pharmaceutical Industries (NYSE:TEVA) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 3.6% this past week